SUPPLEMENTARY MATERIAL - Sustained hair regrowth with continued ritlecitinib treatment through Week 48 in patients with alopecia areata with or without early target responses: post hoc analysis of the ALLEGRO phase 2b/3 trial
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
Supplemental Data, Plain Language Summary, and Video Abstract to accompany article: Piliang et al., Sustained hair regrowth with continued ritlecitinib treatment through Week 48 in patients with alopecia areata with or without early target responses: post hoc analysis of the ALLEGRO phase 2b/3 trial
创建时间：
2024-10-09
